Table 1.
Morphometric and demographic data and surgical procedures
| Levo OR | Levo ICU | Pvalue | |
|---|---|---|---|
| (n = 28) | (n = 18) | ||
| Age (years) | 66 ± 10 | 67 ± 11 | 0.535 |
| Weight (kg) | 82.1 ± 15.9 | 81.5 ± 15.0 | 0.928 |
| Height (m) | 1.76 ± 0.1 | 1.72 ± 0.1 | 0.167 |
| Body mass index (kg/m2) | 26.3 ± 3.9 | 27.9 ± 5.0 | 0.286 |
| Sex (men/women) | 22/6 | 13/5 | 0.622 |
| Procedure | |||
| CABG | 15 | 5 | 0.114 |
| VR | 5 | 8 | 0.051 |
| CABG + VR | 8 | 5 | 0.953 |
| NYHA III/IV | 25 | 16 | 0.966 |
| Coronary artery disease | 23 | 13 | 0.426 |
| LVEF (%) | 31 ± 12 | 36 ± 15 | 0.233 |
| COPD | 9 | 5 | 0.754 |
| Peripheral vascular disease | 7 | 5 | 0.834 |
| Atrial fabrillation | 17 | 9 | 0.474 |
| Hyperlipidaemia | 8 | 8 | 0.270 |
| Nicotine abuse | 6 | 1 | 0.144 |
| Pulmonary arterial hypertension | 12 | 10 | 0.400 |
| Arterial hypertension | 13 | 9 | 0.813 |
| Diabetes mellitus | 16 | 12 | 0.518 |
Data are expressed as mean ± SD, numbers or percentage. CABG, coronary arterial bypass grafting; VR, valve reconstrution and/or replacement; NYHA, New York Heart Association; LVEF, left ventricular ejection fraction; COPD, chronic obstructive pulmonary disease.